☆ 4.7 Article

Antibody Content against Epstein-Barr Virus in Blood Extracellular Vesicles Correlates with Disease Activity and Brain Volume in Patients with Relapsing-Remitting Multiple Sclerosis

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Related references

Note: Only part of the references are listed.

Article Hematology

Mass spectrometry-based analysis on the impact of whole blood donation on the global plasma proteome

Iris C. Kreft et al.

Summary: This study used unbiased mass spectrometry to evaluate longitudinal changes in the global plasma proteome after whole blood donation for new and regular donors. The results showed limited changes in the plasma proteome after donation, and certain proteins were associated with platelets, red blood cells, and neutrophils.

TRANSFUSION (2023)

Add to Collection

Review Immunology

Emerging role of extracellular vesicles in multiple sclerosis: From cellular surrogates to pathogenic mediators and beyond

Paola Loreto Palacio et al.

Summary: Multiple Sclerosis (MS) is a chronic and inflammatory disease of the central nervous system, influenced by genetic and environmental factors. Treatment options for relapsing forms of MS have improved, but there is still a need for better therapies for individuals with progressive MS. This review focuses on the potential role of extracellular vesicles (EVs) and their bioactive cargo in MS pathogenesis, advances and challenges in isolating and characterizing EVs for translational studies, and future perspectives in this field.

JOURNAL OF NEUROIMMUNOLOGY (2023)

Add to Collection

Review Clinical Neurology

Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy

Francesca Aloisi et al.

Summary: Multiple sclerosis is a chronic inflammatory disease that is influenced by genetics and environmental factors, with the Epstein-Barr virus playing a pivotal role in its development. Understanding the mechanisms linking EBV to the pathophysiology of multiple sclerosis is crucial for translating this knowledge into actionable information. Ongoing research is exploring whether EBV causes neuroinflammation through autoimmunity or antiviral immunity, and how EBV interacts with genetic susceptibility to promote immune dysfunction in susceptible individuals. Targeting EBV and developing anti-EBV vaccines in clinical trials bring hope for future treatments and preventive interventions for multiple sclerosis.

LANCET NEUROLOGY (2023)

Add to Collection

Review Clinical Neurology

Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications

Kjetil Bjornevik et al.

Summary: Epidemiological studies have shown that multiple sclerosis is a rare complication of Epstein-Barr virus infection. Recent studies have provided clues on the underlying mechanisms, which could help in developing targeted treatments for MS.

NATURE REVIEWS NEUROLOGY (2023)

Add to Collection

Article Immunology

Dual role of peripheral B cells in multiple sclerosis: emerging remote players in demyelination and novel diagnostic biomarkers

Gabriel Torres Iglesias et al.

Summary: Using a prospective, observational, and single-center study, we found that extracellular vesicles can mediate the delivery of autoantibodies from peripheral B cells, resulting in demyelination in multiple sclerosis. Additionally, we identified that these myelin antibodies in extracellular vesicles could serve as a diagnostic biomarker for multiple sclerosis.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Article Multidisciplinary Sciences

Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM

Tobias Lanz et al.

Summary: Multiple sclerosis (MS) is an autoimmune disease where autoreactive lymphocytes attack the central nervous system. Epstein-Barr virus (EBV) infection has been linked to MS, with molecular mimicry between EBV nuclear antigen 1 (EBNA1) and central nervous system protein GlialCAM. EBNA1 immunization exacerbates disease in MS mouse models and anti-EBNA1 and anti-GlialCAM antibodies are prevalent in MS patients, providing a mechanistic link between MS and EBV and guiding the development of new MS therapies.

NATURE (2022)

Add to Collection

Editorial Material Pharmacology & Pharmacy

Longitudinal Analysis Suggests Epstein--Barr as Cause of Multiple Sclerosis

[Anonymous]

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

Add to Collection

Article Immunology

Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study

Maria Inmaculada Dominguez-Mozo et al.

Summary: The study analyzed the prevalence and levels of EBV antibodies in MS patients in Spain, as well as their interactions with environmental and genetic risk factors. The results showed higher antibody levels in MS patients compared to healthy controls.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Kjetil Bjornevik et al.

Summary: This study suggests that multiple sclerosis may be caused by Epstein-Barr virus, with no direct association with other viral infections. These findings provide clues to the primary cause of MS.

SCIENCE (2022)

Add to Collection

Article Neurosciences

Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands

Zhe Wang et al.

Summary: The study found that EBV nuclear antigens are associated with multiple sclerosis (MS), and MS patients have significantly higher binding of intrathecal IgG to the EBNA1 epitope compared to EBNA2. This further confirms the potential role of EBV in the etiology of MS.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2021)

Add to Collection

Review Biotechnology & Applied Microbiology

Extracellular vesicles in neuroinflammation: Pathogenesis, diagnosis, and therapy

Jing Ruan et al.

Summary: Extracellular vesicles play a crucial role in intercellular communication in the central nervous system, influencing the pathogenesis and treatment of neuroinflammatory diseases.

MOLECULAR THERAPY (2021)

Add to Collection

Review Immunology

Antigen-Specific Immune Tolerance in Multiple Sclerosis-Promising Approaches and How to Bring Them to Patients

Andreas Lutterotti et al.

Summary: Antigen-specific tolerance induction offers personalized treatment for multiple sclerosis by targeting antigens and core pathomechanisms, requiring distinct clinical development approaches. Key aspects include patient selection, outcome measures, demonstrating mechanisms of action, and positioning in the spectrum of MS treatments.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Potential Roles of Extracellular Vesicles as Biomarkers and a Novel Treatment Approach in Multiple Sclerosis

Maria Gutierrez-Fernandez et al.

Summary: Extracellular vesicles (EVs) play a key role as potential biomarkers in multiple sclerosis (MS), aiding in monitoring disease activity and progression and discovering new pathways for therapeutic targets. EVs also have the potential to serve as treatment and vaccine delivery vehicles for immune tolerance restoration in MS autoimmunity.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies

Amit Bar-Or et al.

TRENDS IN MOLECULAR MEDICINE (2020)

Add to Collection

Article Cell & Tissue Engineering

Low dose of extracellular vesicles identified that promote recovery after ischemic stroke

Laura Otero-Ortega et al.

STEM CELL RESEARCH & THERAPY (2020)

Add to Collection

Review Clinical Neurology

Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors

Benjamin M. Jacobs et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

Add to Collection

Review Immunology

Epstein-Barr Virus and Multiple Sclerosis

Gunnar Houen et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Review Neurosciences

Neuroimmune Crosstalk through Extracellular Vesicles in Health and Disease

Jean-Christophe Delpech et al.

TRENDS IN NEUROSCIENCES (2019)

Add to Collection

Article Multidisciplinary Sciences

Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk

Katarina Tengvall et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Add to Collection

Article Immunology

Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis

Caterina Veroni et al.

JOURNAL OF NEUROINFLAMMATION (2018)

Add to Collection

Article Clinical Neurology

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Alan J. Thompson et al.

LANCET NEUROLOGY (2018)

Add to Collection

Article Neurosciences

Cerebrospinal fluid anti-Epstein-Barr virus specific oligoclonal IgM and IgG bands in patients with clinically isolated and Guillain-Barre syndrome

Diana Ferraro et al.

JOURNAL OF NEUROVIROLOGY (2017)

Add to Collection

Review Clinical Neurology

Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis

Tomas Olsson et al.

NATURE REVIEWS NEUROLOGY (2017)

Add to Collection

Article Immunology

Association of serum Epstein-Barr nuclear antigen-1 antibodies and intrathecal immunoglobulin synthesis in early multiple sclerosis

Catherina Pfuhl et al.

JOURNAL OF NEUROIMMUNOLOGY (2015)

Add to Collection

Article Immunology

Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies

Massimiliano Castellazzi et al.

JOURNAL OF NEUROINFLAMMATION (2014)

Add to Collection

Letter Clinical Neurology

Epstein-Barr Virus in the Central Nervous System and Cervical Lymph Node of a Patient With Primary Progressive Multiple Sclerosis

Barbara Serafini et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2014)

Add to Collection

Review Clinical Neurology

Defining the clinical course of multiple sclerosis The 2013 revisions

Fred D. Lublin et al.

NEUROLOGY (2014)

Add to Collection

Article Clinical Neurology

B-Cell Enrichment and Epstein-Barr Virus Infection in Inflammatory Cortical Lesions in Secondary Progressive Multiple Sclerosis

Roberta Magliozzi et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)

Add to Collection

Article Immunology

Cerebrospinal BAFF and Epstein-Barr virus-specific oligoclonal bands in multiple sclerosis and other inflammatory demyelinating neurological diseases

Diego Franciotta et al.

JOURNAL OF NEUROIMMUNOLOGY (2011)

Add to Collection

Article Immunology

EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2

Jan D. Luenemann et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2008)

Add to Collection

Review Clinical Neurology

Oligoclonal bands and antibody responses in Multiple Sclerosis

J Correale et al.

JOURNAL OF NEUROLOGY (2002)

Add to Collection

Article Clinical Neurology

Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis

KH Rand et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.